The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron

Steinberg, 1989, The cholesterol controversy is over. Why did it take so long?, Circulation, 80, 1070, 10.1161/01.CIR.80.4.1070 Henriksen, 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells, Proc Natl Acad Sci USA, 78, 6499, 10.1073/pnas.78.10.6499 Goldstein, 1979, Binding sites on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition, Proc Natl Acad Sci USA, 76, 333, 10.1073/pnas.76.1.333 Kuzuya, 1991, Lipid peroxidation and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells, Biochim Biophys Acta, 1096, 155, 10.1016/0925-4439(91)90054-D Quinn, 1987, Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis, Proc Natl Acad Sci USA, 84, 2995, 10.1073/pnas.84.9.2995 Quinn, 1985, Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein, Proc Natl Acad Sci USA, 82, 5949, 10.1073/pnas.82.17.5949 Sullivan, 1981, Iron and sex differences in heart disease risk, Lancet, 1, 1203 Salonen, 1992, High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men, Circulation, 86, 803, 10.1161/01.CIR.86.3.803 Kiechl, 1994, Body iron stores and presence of carotid atherosclerosis, Arterioscler Thomb, 14, 1625, 10.1161/01.ATV.14.10.1625 Halle, 1997, Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease, Atherosclerosis, 128, 235, 10.1016/S0021-9150(96)05994-1 Manttai, 1994, Serum ferritin and ceruloplasmin as coronary risk factors, Eur Heart J, 15, 1599, 10.1093/oxfordjournals.eurheartj.a060440 Solymoss, 1994, The place of ferritin among risk factors associated with coronary artery disease, Coron Artery Dis, 5, 231, 10.1097/00019501-199403000-00008 Moore, 1995, No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study, Am J Epidemiol, 141, 719, 10.1093/oxfordjournals.aje.a117493 Aronow, 1996, Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged ≥62 years, Am J Cardiol, 78, 678, 10.1016/S0002-9149(96)00394-3 Rauramaa, 1994, Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men, Eur Heart J, 15, 1020, 10.1093/oxfordjournals.eurheartj.a060623 Kritharides, 1995, Macrophages require both iron and copper to oxidize low-density lipoprotein in Hank's balanced salt solution, Arch Biochem Biophys, 323, 127, 10.1006/abbi.1995.0018 Smith, 1992, Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions, Biochem J, 286, 901, 10.1042/bj2860901 Yuan, 1996, Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis, Atherosclerosis, 124, 61, 10.1016/0021-9150(96)05817-0 Pang, 1996, Increased ferritin gene expression in atherosclerotic lesions, J Clin Invest, 97, 2204, 10.1172/JCI118661 Araujo, 1995, Iron overload augments the development of atherosclerotic lesions in rabbits, Artrioscler Thromb Vasc Biol, 15, 1172, 10.1161/01.ATV.15.8.1172 Salonen, 1995, Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers, J Intern Med, 237, 161, 10.1111/j.1365-2796.1995.tb01156.x Thong, 1996, Elemental changes in atherosclerotic lesions using nuclear microscopy, Cell Mol Biol, 42, 103 Esterbauer, 1987, Autooxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J Lipid Res, 28, 495, 10.1016/S0022-2275(20)38678-8 Jürgens, 1993, Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a), Arterioscler Thromb, 13, 1689, 10.1161/01.ATV.13.11.1689 Hoff, 1993, Structural and functional changes in LDL after modification with both LDL and malonaldehyde, J Lipid Res, 34, 1209, 10.1016/S0022-2275(20)37708-7 Chen, 1992, Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination, Biochem J, 288, 249, 10.1042/bj2880249 Selley, 1988, Effect of 4-hydroxy-2,3-trans-nonenal on platelet function, Thromb Haemost, 59, 143, 10.1055/s-0038-1642743 Ardlie, 1989, Platelet activation by oxidatively modified low density lipoproteins, Atherosclerosis, 76, 117, 10.1016/0021-9150(89)90094-4 Esterbauer, 1967, Uber die Wirkungen von Aldehyden auf gesunde und maligne Zellen, 3. mitt: Synthese von homologen 4-hydroxy-2-alkenalen II, Monatsch Chem, 98, 1994, 10.1007/BF01167162 Hatch, 1968, Practical methods for plasma lipoprotein analysis, Adv Lipid Res, 6, 1, 10.1016/B978-1-4831-9942-9.50008-5 Lowry, 1951, Protein measurement with the protein phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Cameron, 1982, The facilitating effects of adrenaline on platelet aggregation, Prostaglandins Leukotriene Med., 9, 117, 10.1016/0262-1746(82)90077-4 Selley, 1989, Quantitative determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometry, J. Chromatogr (Biomed Appl), 488, 329, 10.1016/S0378-4347(00)82957-6 Schafer, 1986, Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin, J Clin Invest, 78, 73, 10.1172/JCI112576 Salvemini, 1989, Superoxide anions enhance platelet adhesion and aggregation, Br J Pharmacol, 97, 1145, 10.1111/j.1476-5381.1989.tb12572.x Del Principe, 1985, Hydrogen peroxide has a role in the aggregation of human platelets, FEBS Lett, 185, 142, 10.1016/0014-5793(85)80758-4 Handin, 1977, Enhancement of platelet function by superoxide anion, J Clin Invest, 59, 959, 10.1172/JCI108718 Ohyashiki, 1991, Oxygen-radical mediated lipid peroxidation and inhibition of ADP-induced platelet aggregation, Arch Biochem Biophys, 288, 282, 10.1016/0003-9861(91)90196-P Pratico, 1992, Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen, J Lab Clin Med, 119, 364 Iuliano, 1997, Oxygen free radicals and platelet activation, Free Radic Biol Med, 22, 999, 10.1016/S0891-5849(96)00488-1 Aviram, 1990, Platelet secretory products increase LDL oxidation, enhance its uptake by macrophages and reduce its fluidity, Arteriosclerosis, 10, 559, 10.1161/01.ATV.10.4.559 Ardlie, 1984, Platelet activation by circulating levels of hormones: a possible link in coronary heart disease, Thromb Res, 36, 315, 10.1016/0049-3848(84)90322-0 Selley, 1994, Dipyridamole inhibits the oxidative modification of low density lipoprotein, Atherosclerosis, 111, 91, 10.1016/0021-9150(94)90194-5 Parthasarathy, 1986, Probucol inhibits the oxidative modification of low density lipoprotein, J Clin Invest, 77, 641, 10.1172/JCI112349 Iuliano, 1989, Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicals, Lipids, 24, 430, 10.1007/BF02535151 Bridges, 1991, Probucol, a superoxide free radical scavenger in vitro, Atherosclerosis, 89, 263, 10.1016/0021-9150(91)90068-E Iuliano, 1994, Role of hydroxyl radicals in the activation of human platelets, Eur J Biochem, 221, 695, 10.1111/j.1432-1033.1994.tb18782.x Iuliano, 1992, Involvement of phospholipase A2 in H2O2-dependent platelet aggregation, Platelets, 2, 87, 10.3109/09537109209003393 Ross, 1981, Atherosclerosis: a problem of the biology of arterial cell walls and their interactions with blood components, Atherosclerosis, 1, 293 Iuliano, 1992, Free radical-mediated platelet activation by hemoglobin released from red blood cells, Arch Biochem Biophys, 299, 220, 10.1016/0003-9861(92)90267-Z Sambrano, 1994, Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein, Proc Natl Acad Sci USA, 91, 3265, 10.1073/pnas.91.8.3265 Kaneko, 1988, Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells, Cell-Biol Interact, 67, 295, 10.1016/0009-2797(88)90065-8 Muller, 1996, Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophages, FEBS Lett, 388, 165, 10.1016/0014-5793(96)00559-5